T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Weill Medical College of Cornell University
University of California, San Francisco
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
MOMA Therapeutics
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
Hoffmann-La Roche
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
BicycleTx Limited
Royal Marsden NHS Foundation Trust
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
North Eastern German Society of Gynaecological Oncology
Providence Health & Services
National Cancer Institute (NCI)
Astellas Pharma Inc
Rigshospitalet, Denmark
Pfizer
Canadian Cancer Trials Group
Pfizer
Providence Health & Services
Ohio State University Comprehensive Cancer Center
Eli Lilly and Company
Nagoya City University
Georgetown University
Medicine Invention Design, Inc
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Abramson Cancer Center at Penn Medicine
Novartis
AstraZeneca
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Amgen
Ottawa Hospital Research Institute
Seagen Inc.
MedSIR
Hospital Universitari de Bellvitge